|
The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: ---------- Celsius Resources Ltd - Philippines-focused gold and copper producer - Raises £530,000 via placing to institutional and other investors at a price of 0.5 pence per share. The placing was conducted by way of an accelerated bookbuild. Placing shares represent around 3% of the company’s share capital. Proceeds will be used to progress corporate and operational strategy, and for general working capital purposes. ---------- Built Cybernetics PLC - London-based company focused on smart buildings - Announces the acquisition of Belfast-based 3DEO (NI) Ltd effected by a previously dormant wholly owned Built Cybernetics subsidiary, which has been renamed MapBI Ltd. Total consideration is £100,000 in cash, of which £75,000 has been paid, with a further payment of £25,000 due in six months. Additionally, up to £125,000 is payable from a portion of future MapBI profits. ‘We’re delighted to have acquired this complementary business, which should allow us to accelerate the growth of recurring software revenues and we expect a strong start from MapBI in the current year,’ company says. ---------- Golden Rock Global PLC - Hong Kong-based special purpose acquisition company - Plans to raise up to £1.1 million by the issue of convertible loan notes due 2028 with a conversion price of 3 pence per share. The convertible notes will bear interest of 8% from the date of issue. Noteholders will also receive one warrant for every two shares issued as a result of the conversion of the convertible notes. Each warrant provides the holder with the right to subscribe for one share at a price of 3p, exercisable for three years after issuance. To date, Golden Rock has entered into agreements raising £855,000. ---------- First Class Metals PLC - London-listed gold and critical metals explorer in Ontario - Secures £500,000 in interest-free funding through a convertible loan note issue with an international institutional investor to advance drilling at its North Hemlo property in Ontario. The note carries a 12-month maturity, with conversion at 80% of the lowest five-day VWAP prior to conversion. The investor will also receive 7.9 million warrants, exercisable at 120% of Tuesday’s closing price of 2.65 pence. Funds will be used to launch drilling on the Dead Otter trend, targeting the 19 g/t gold anomaly and other promising zones before winter conditions halt fieldwork. Chief Executive James Knowles says: ‘This agreement with the investor provides FCM with the immediate flexibility to advance exploration at North Hemlo, where the planned drilling campaign represents a pivotal and exciting phase for the company.’ ---------- Seeing Machines Ltd - Canberra, Australia-based designer of vehicle operator monitoring systems - Reports production of 510,167 units in the three months to September, up 26% from 405,669 the year prior, and up 4.5% from 488,294 in the prior quarter. Cars on the road with Seeing Machines’ driver and occupant monitoring system technology increase 62% on-year to 4.2 million from 2.6 million. Seeing Machines says Guardian sales for the quarter were below expectations due to delayed large deals, which slipped to the present period. ‘Although there was some slippage in Q1 sales, we are making good progress with Guardian across the aftermarket sector and early results for Q2 FY2026 are promising. We have a strong pipeline of opportunities with a number of large customers completing trials, pilots and commercial contract terms,’ says Chief Executive Paul McGlone. ‘We remain on track to achieve our cashflow break-even run rate target by the end of this calendar year,’ he adds. ---------- Nuformix PLC - London-based developer of treatments for fibrosis and oncology - US Food & Drug Administration requests further clarification for one specific element of the application for orphan drug designation in Idiopathic Pulmonary Fibrosis for tranilast. Nuformix says it will submit a response ‘as soon as possible’ using existing data and information. Upon further review the FDA will issue a designation confirmation letter, a request for more information or a denial, the firm notes. ‘I remain confident the process will reach a successful conclusion and whilst we await the FDA’s further response we continue to progress discussions with potential future licensing partners and will provide further updates in due course as appropriate,’ comments Nuformix Executive Director Dan Gooding. ---------- MicroSalt PLC - London-based provider of low-sodium salt products - Announces a new partnership with Daiya Foods Inc, a global presence in dairy-free and plant-based food innovation. MicroSalt receives an initial $50,000 order to begin production and its projected 2026 volume is around $500,000. MicroSalt expects to be integrated into the Daiya Foods portfolio of product lines, with an initial focus on cheese and pizza dough. ‘This collaboration demonstrates the versatility of MicroSalt’s technology across diverse food categories-from dairy-free alternatives to frozen meals and sauces,’ says Chief Executive Rick Guiney. ---------- Renalytix PLC - London-based diagnostics company - Says ‘pivotal’ kidneyintelX.dkd data is published in Diabetes Care Journal of the American Diabetes Association. Findings include kidneyintelX.dkd provides improved risk classification across all of the established risk groups as presented in the ’Kidney Disease: Improving Global Outcomes’ clinical guidelines. In addition, treatment with SGLT2i front line therapy in patients classified as moderate or high risk by kidneyintelX.dkd results in a significant risk reduction, with the high risk treated group twice as likely to reduce their kidneyintelX.dkd risk level at 1 year compared to those not receiving treatment. ---------- Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
